FBIO (Fortress Biotech) Float Percentage Of Total Shares Outstanding: 77.21% (As of Jun. 30, 2026)


FBIO Fortress Biotech Inc FBIO
44 GF Score
Price $2.99
GF Value $1.23
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Fortress Biotech Float Percentage Of Total Shares Outstanding?

Fortress Biotech FBIO +1.36% 44 Float Percentage Of Total Shares Outstanding is 77.21% as of Jun. 30, 2026. GuruFocus rates FBIO with a GF Score™ of 44/100 and a GF Value™ of $1.23 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Fortress Biotech's float shares is 25.65 Mil. Fortress Biotech's total shares outstanding is 33.22 Mil. Fortress Biotech's float percentage of total shares outstanding is 77.21%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Fortress Biotech's Insider Ownership is 29.93%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Fortress Biotech's Institutional Ownership is 19.54%.

FBIO
44GF Score
Fortress Biotech Inc FBIO
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fortress Biotech Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Fortress Biotech's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=25.65/33.22
=77.21%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 77.21% mean?
Fortress Biotech (FBIO) has a Float Percentage Of Total Shares Outstanding of 77.21% as of Jun. 30, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Fortress Biotech and its competitors.
Is Fortress Biotech's Float Percentage Of Total Shares Outstanding too high?
Fortress Biotech's current Float Percentage Of Total Shares Outstanding is 77.21%. Overall, Fortress Biotech has a GF Score™ of 44/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fortress Biotech's Float Percentage Of Total Shares Outstanding compare to RLYB and INO?
Fortress Biotech's Float Percentage Of Total Shares Outstanding of 77.21% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Fortress Biotech and its competitors. Fortress Biotech's current Float Percentage Of Total Shares Outstanding is 77.21%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fortress Biotech stock overvalued right now?
Based on GuruFocus' analysis, Fortress Biotech (FBIO) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.23, compared to a current price of $2.99 — trading 142.7% above its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 77.21%. Fortress Biotech's overall GF Score™ is 44/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Fortress Biotech (FBIO), the current Float Percentage Of Total Shares Outstanding is 77.21% as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fortress Biotech (FBIO) Overvalued in 2026?

Based on GuruFocus' analysis, Fortress Biotech stock appears to be overvalued. The current stock price of $2.99 is trading 142.7% above its estimated GF Value™ of $1.23. GuruFocus considers Fortress Biotech to be Significantly Overvalued.

Key valuation signals for FBIO:

  • Float Percentage Of Total Shares Outstanding: 77.21%
  • GF Value™: $1.23 vs. price of $2.99 (142.7% above fair value)
  • GF Score™: 44/100 with 6 warning signs

No single metric tells the full story. See the FBIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fortress Biotech Business Description

Address 1111 Kane Concourse, Suite 301, Bay Harbor Island, FL, USA, 33154
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.
44GF Score

Get the complete analysis for FBIO

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.99
Price
$1.23
GF Value